Skip to main content

Editas Medicine, Inc 10-Q for FY2020 Q3

Editas Medicine, Inc. (EDIT)

10-Q 2020-11-06 For: 2020-09-30
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on November 6, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).

Headline figures

Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$62.84M
up 1533.1% from $3.85M a year earlier
Net income
$7.82M
compared with a net loss of $32.94M a year earlier
Diluted EPS
$0.12
compared with -$0.66 a year earlier